3Zwaan C M,Kaspers G J,Heters R,et al.Cellular drug resistance in childhood acute myeloid leukemia is related to chromosomal abnormalities[J].Blood,2002,100(9):3352-3360.
4Norgaard J M,Langkjer S T,Palshof T,et al.Pretreatment leukaemia cell drug resistance is correlated to clinical outcome in acute myeloid leukaemia[J].Eur J Haematol,2001,66(3):160-167.
5Head D R.Revised classification of acute myeloid leukemia[J].Leukemia,1996,10(11):1826-1831.
6Lima C S,Vassalo J,t.orand-Metze I,et al.The significance of trilineage myelodysplasia in de novo acute myeloblastic leukemia:clinical and laboratory features[J].Haematologia(Budap),1997,28(2):85-95.
7Kahl C,Florsehutz A,Muller G,et al.Prognostic significance of dysplastic features of hematopoiesis in patients with de novo acute myelogenous leukemia[J].Ann Hematol,1 997,75(3):91-94.
8Steube K G,Gignac S M,Hu Z B,et al.In vitro culture studies of childhood myelodysplastic syndrome:establishment of the cell line MUTZ-1[J].Leuk Lymphoma,1997,25(3-4):345-363.
9HP Koeffler,Billing R,Lusis A J,et al.An undifferentiated variant derived from the human acute myelogenous leukemia cell line (KG-1)[J].Blood,1980,56(2):265-273.
10Feldman E J,Seiter K P,Ahmed T,et al.Homoharringtonine in patients with myelodysplastic syndrome (MDS) and MDS evolving to acute myeloid leukemia[J].Leukemia,1996,10(1):40-42.
